Dornase Alfa and Cisplatin in Refractory Germ Cell Cancer.
NCT07121322
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
33
Enrollment
OTHER_GOV
Sponsor class
Conditions
Refractory Germ Cell Tumors
Dornase Alfa
Interventions
DRUG:
dornase alfa i.v. and cisplatin
Sponsor
National Cancer Institute, Slovakia